Proteome Dynamics and Bioinformatics Reveal Major Alterations in the Turnover Rate of Functionally Related Cardiac and Plasma Proteins in a Dog Model of Congestive Heart Failure
Overview
Authors
Affiliations
Protein pool turnover is a critically important cellular homeostatic component, yet it has been little explored in the context of heart failure (HF) pathophysiology. We used in vivo H labeling/proteome dynamics for the nonbiased discovery of turnover alterations involving functionally linked cardiac and plasma proteins in canine tachypacing-induced HF, an established preclinical model of dilated cardiomyopathy. Compared with controls, dogs with congestive HF displayed bidirectional turnover changes of 28 cardiac proteins, that is, a reduced half-life of several key enzymes involved in glycolysis, homocysteine metabolism and glycogenesis, and increased half-life of proteins involved in proteolysis. Changes in plasma proteins were more modest: only 5 proteins, involved in various functions including proteolysis inhibition, hemoglobin, calcium and ferric iron binding, displayed increased or decreased turnover rates. In other dogs undergoing cardiac tachypacing, we infused for 2 weeks the myokine Follistatin-like protein 1, known for its ameliorative effects on HF-induced alterations. Proteome dynamics proved very sensitive in detecting the partial or complete prevention, by Follistatin-like protein 1, of cardiac and plasma protein turnover alterations. In conclusion, our study unveiled, for the first time in a large mammal, numerous HF-related alterations that may serve as the basis for future mechanistic research and/or as conceptually new molecular markers.
Measuring HSD17β13 protein turnover in mouse liver with DO metabolic labeling and hybrid LC-MS.
Shi Y, Del Rosario A, Wang S, Kang L, Liu H, Rady B Bioanalysis. 2025; 17(3):151-159.
PMID: 39819243 PMC: 11853646. DOI: 10.1080/17576180.2025.2452757.
Preclinical Models of Cardiac Disease: A Comprehensive Overview for Clinical Scientists.
van Doorn E, Amesz J, Sadeghi A, de Groot N, Manintveld O, Taverne Y Cardiovasc Eng Technol. 2024; 15(2):232-249.
PMID: 38228811 PMC: 11116217. DOI: 10.1007/s13239-023-00707-w.
Tachycardia-induced metabolic rewiring as a driver of contractile dysfunction.
Tu C, Caudal A, Liu Y, Gorgodze N, Zhang H, Lam C Nat Biomed Eng. 2023; 8(4):479-494.
PMID: 38012305 PMC: 11088531. DOI: 10.1038/s41551-023-01134-x.